Exploring High-Throughput Drug Sensitivity Testing in Neuroblastoma Cell Lines and Patient-Derived Tumor Organoids in the Era of Precision Medicine

Karin P.S. Langenberg,Sander R. van Hooff,Bianca Koopmans,Josephine G.M. Strijker,Waleed M. Kholosy,Kimberley Ober,Danny A. Zwijnenburg, Jessica J.F. van der Hoek,Kaylee M. Keller,Lindy Vernooij,Linda G Schild,Eleonora J. Looze,Marli E. Ebus,Anke H.W. Essing, Paula de Vree,Michelle L. Tas,Yvette A.H. Matser,Judith Wienke,Richard Volckmann,Bastiaan B.J. Tops

European Journal of Cancer（2025）

Cited 0|Views2

Key words

Neuroblastoma,Organoid,High-throughput drug screening,Precision Medicine,Molecular Biology,Next-Generation Sequencing,Molecular Targeted Therapy,Cancer,Child,Adolescent

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined